婴儿毛细支气管炎鼻咽脂质组内型与儿童哮喘风险:多中心前瞻性研究
该多中心前瞻性队列纳入917例因毛细支气管炎住院的婴儿,基于临床、病毒和鼻咽脂质组数据聚类识别出4种内型。其中D型(特应性、鞘脂低)患儿6岁前哮喘风险显著高于A型(50% vs 22%,未校正OR 3.60,95%CI 2.31-5.62,p<0.001),并伴有鞘脂代谢通路差异表达。
要点
- 毛细支气管炎可分为4种临床-病毒-脂质组内型,哮喘风险差异显著。
- D型(特应性、鞘脂低)患儿哮喘风险最高,50% vs A型22%。
- 鞘脂代谢通路在D型中差异表达,或为潜在机制。
核心结论
- 整合临床、病毒和脂质组数据可识别毛细支气管炎内型,其哮喘风险显著不同。
研究设计与样本
- 多中心前瞻性队列研究,纳入917例年龄<12月因毛细支气管炎住院的婴儿。
- 采用聚类方法基于住院时临床、病毒和鼻咽脂质组数据识别内型。
- 拟合混合效应逻辑回归模型分析内型与6岁前哮喘风险的纵向关联。
主要发现
- 识别出4种内型:A型经典混合(n=263)、B型重症鞘脂高(n=281)、C型中等磷脂高(n=212)、D型特应性鞘脂低(n=161)。
- D型患儿父母哮喘比例、IgE致敏和鼻病毒感染的 proportion 更高,鞘脂(如鞘磷脂、神经酰胺)水平低。
- 与A型相比,D型6岁前哮喘风险显著更高(50% vs 22%;未校正OR 3.60;95%CI 2.31-5.62;p<0.001)。
- D型多不饱和脂肪酸(如二十二碳六烯酸)丰度显著降低(FDR=0.01)。
- 通路分析显示鞘脂代谢通路在D型中差异表达(FDR=0.048)。
临床怎么用
- 对毛细支气管炎婴儿可结合临床、病毒和脂质组特征进行内型划分,识别哮喘高风险亚群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bronchiolitis is the leading cause of hospitalisation of US infants and an important risk factor for childhood asthma. Recent evidence suggests that bronchiolitis is clinically heterogeneous. We sought to derive bronchiolitis endotypes by integrating clinical, virus and lipidomics data and to examine their relationship with subsequent asthma risk. METHODS: This is a multicentre prospective cohort study of infants (age <12 months) hospitalised for bronchiolitis. We identified endotypes by applying clustering approaches to clinical, virus and nasopharyngeal airway lipidomic data measured at hospitalisation. We then determined their longitudinal association with the risk for developing asthma by age 6 years by fitting a mixed-effects logistic regression model. To account for multiple comparisons of the lipidomics data, we computed the false discovery rate (FDR). To understand the underlying biological mechanism of the endotypes, we also applied pathway analyses to the lipidomics data. RESULTS: Of 917 infants with bronchiolitis (median age, 3 months), we identified clinically and biologically meaningful lipidomic endotypes: (A) cinicalclassiclipidmixed (n=263), (B) clinicalseverelipidsphingolipids-high (n=281), (C) clinicalmoderatelipidphospholipids-high (n=212) and (D) clinicalatopiclipidsphingolipids-low (n=161). Endotype A infants were characterised by 'classic' clinical presentation of bronchiolitis. Profile D infants were characterised by a higher proportion of parental asthma, IgE sensitisation and rhinovirus infection and low sphingolipids (eg, sphingomyelins, ceramides). Compared with endotype A, profile D infants had a significantly higher risk of asthma (22% vs 50%; unadjusted OR, 3.60; 95% CI 2.31 to 5.62; p<0.001). Additionally, endotype D had a significantly lower abundance of polyunsaturated fatty acids (eg, docosahexaenoic acid; FDR=0.01). The pathway analysis revealed that sphingolipid metabolism pathway was differentially expressed in endotype D (FDR=0.048). CONCLUSIONS: In this multicentre prospective cohort study of infants with bronchiolitis, integrated clustering of clinical, virus and lipidomic data identified clinically and biologically distinct endotypes that have a significantly differential risk for developing asthma.Delete.
引用
- Fujiogi M, Zhu Z, Raita Y, et al. Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study. Thorax. 2022. PMID: 35907638. doi:10.1136/thorax-2022-219016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。